Puteaux Cedex, FRANCE – 28th January: SGD Pharma, a leading supplier of glass primary packaging in the pharmaceutical industry, has been awarded a ‘platinum’ rating by EcoVadis, positioning it in the top 1% of all companies rated worldwide. This highlights SGD Pharma’s commitment to sustainable practices and corporate social responsibility (CSR).
Source: Analytical Cannabis - January 14th 2021
I was proud and happy to visit the Sucy-en-Brie plant this week and to meet the very dedicated team in charge of a major revamping of the factory, coordinated by Philippe Dubois (photo). The project, which will last till March 2021, has now broken ground. This Capex, 31 million€ in total, is the biggest SGD Pharma investment since the Saint-Quentin-Lamotte plant construction.
How Does SGD Pharma Envision the Future of the Pharma/Biopharma Industry?
Source: Pharma's Almanac - December 2020
SGD Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry.
4-Dec-2020 - Manufacturing Chemist - https://manufacturingchemist.com/news/article_page/Moulded_glass_vials_s...
Although different materials have been trialled and tested, glass remains the most widely used type of primary container for parenteral drug products, writes Dr Jingwei Zhang, R&D Director, SGD Pharma
